Skip to main content
. 2016 Dec 1;11:164. doi: 10.1186/s13023-016-0539-3

Fig. 2.

Fig. 2

Number of CDR submissions for drugs for rare diseases by indicated disease prevalence. Numbers above columns indicate the number of submissions